Found 35 matching trials
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer NA To assess the efficacy and feasibility of high-dose intensity-modulated rad...
Show More Location
Shanghai Genernal Hospital
Learn More & Join Trial
Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer PHASE2 Small cell lung cancer (SCLC) remains a challenging disease with poor progn...
Show More Location
Peking University Cancer Hospital and Institute
Learn More & Join Trial
Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma PHASE3 Hyperfractionated radiation therapy (RT) to 72.0 Gy with BCNU will be compa...
Show More Location
Multiple Locations
Learn More & Join Trial
Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) PHASE3 This study is expected to enroll 182 patients with partial response or stab...
Show More Location
Multiple Locations
Learn More & Join Trial
Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma PHASE2 Based on the radiobiological findings that accelerated tumor repopulation i...
Show More Location
People's Hospital of Guangxi Zhuang Autonomous Region
Learn More & Join Trial
Preoperative Hyperfractionated Radiotherapy or Radiochemotherapy in Locally Advanced Rectal Cancer. PHASE3 Clinical objective of the study is to compare the rates of pathologic respo...
Show More Location
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch
Learn More & Join Trial
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer EARLY_PHASE1 Radiotherapy (RT) with concurrent chemotherapy represents the state of the ...
Show More Location
Department of Radiation Oncology; Duke University Medical Center
Learn More & Join Trial
Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck Cancer PHASE2 The purpose of this study is to explore the activity of ZD1839 added to con...
Show More Location
The University of Chicago Medical Center
Learn More & Join Trial
Donor Stem Cell Transplantation Using ฮฑ/ฮฒ+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors PHASE2 This study is being done to learn whether a new method to prevent rejection...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies PHASE2 The purpose of this study is to find out the effects of using a system call...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial